$127.67
-0.73-0.57%
At close: -
$127.67
00.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Latest news for Ascendis Pharma (NASDAQ:ASND) Stock
Ascendis Pharma Stock (NASDAQ: ASND)
Categories: All
Tuesday, November 05, 2024
Monday, November 04, 2024
Wednesday, October 30, 2024
Wednesday, October 23, 2024
Monday, October 21, 2024
Tuesday, October 08, 2024
Monday, September 30, 2024
Thursday, September 26, 2024
Wednesday, September 25, 2024
Tuesday, September 24, 2024
Monday, September 23, 2024
Sunday, September 22, 2024
Friday, September 20, 2024
Wednesday, September 18, 2024
Tuesday, September 17, 2024
Monday, September 16, 2024
- Despite Being First Mover, BioMarin's Voxzogo For Dwarfism To Face Pressure From Ascendis' Candidate In Near Term
- Crude Oil Surges Over 1%; Instil Bio Shares Plunge
- Ascendis Pharma's Rare Dwarfism Candidate Shows Promise In Trial, FDA Submission Expected Next Year
- Alcoa, Lattice Semiconductor, Stratasys And Other Big Stocks Moving Higher On Monday
- Ascendis Pharma shares are trading higher aft...
- Cantor Fitzgerald Reiterates Overweight on As...
- Ascendis Pharma Announced Topline Data From T...
Friday, September 13, 2024
Wednesday, September 11, 2024
Monday, September 09, 2024
Thursday, September 05, 2024
Wednesday, September 04, 2024
- JP Morgan Maintains Overweight on Ascendis Ph...
- Ascendis Pharma Faces Challenges With Skytrofa And Yorvipath Pricing: Analysts Weigh In
- TD Cowen Maintains Buy on Ascendis Pharma, Lo...
- B of A Securities Maintains Buy on Ascendis P...
- Wells Fargo Maintains Overweight on Ascendis ...
- Rare Disease-Focused Ascendis Pharma Stock Falls On Underwhelming Q2 Earnings, Guidance Cut
- Core & Main Reports Downbeat Results, Joins Rev Group, PagerDuty, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
- Cantor Fitzgerald Maintains Overweight on Asc...
- Ascendis Pharma shares are trading lower afte...